top of page
Dynami Pharma has the experience, the right connections, great record of successful deals to support companies and Startups to grow or expand their business abroad or advance in their developments, partnerships, licensing, raising funds, strategic investments and performance improvements, combined with market insights, regulatory knowledge and accessibility; the best choice to accelerate the achievement of strategic goals, markets expansions and growth aspiration. 
About us

About Us

​Dynami Pharma operates in the Bio-Pharmaceutical, Medical Devices, Animal Health and general Healthcare industry, supporting and partnering with small/startups to big size companies aiming to grow, expand locally or outside their country/region of origin, licensing, building partnerships, JVs and representations, with highly experienced partners, all having significant expertise and successful careers in the top Pharmaceutical (human and animal health) and Biotech industries.  We also invest with our partners as well as find potential investors to support strategic goals and we have particular focus and success in facilitating companies interested in expanding their reach to territories abroad, including the emerging markets. This is realized through utilization of an extensive network in the United States, Europe, Asia Pacific and Latin America, coupled with established proficiency within these regions in the areas of Business Development, Joint Ventures, Licensing, Manufacturing, Quality, Regulatory, Acquisitions as well as Capital investments / funding to support development for startup companies from “angel” series throughout their IPO and beyond. Our capabilities also include strategic partners with extensive knowledge with management support to turn around business results and performance, build strategic plans to unlock potential growth through Business and Operational Excellence initiatives.

nothing

Expertise

Dynami understands what our clients need and develops a tailored solution as a real partner to reach the established goals faster and better than planned.
Our main specialized focus are on Business and Product Development, Acquisitions and Divestiture, Licensing, Joint Ventures and joint investments, Startup processes to grow, Due Diligences, Business performance and Operations Excellence.

BUSINESS DEVELOPMENT

-Our services focus on our clients' most critical needs, strategic movements towards faster growth and opportunities to increase market share, including partnerships, JVs, acqusitions, licensing, capital investors, geographic presence and distribution, expansion to other territories and business niches.

-We have over $5B worth of worldwide transaction experience in Business Development, Startups support and deals across the Americas and Europe working with multinationals and top leader local companies.

 

-With first-hand insight of key industry trends, investment opportunities, and the right connections, we love what we do and we love bringing success to our partners and clients.

BUSINESS GROWTH

- Our Mission is to partner and provide assistance and guidance to bio-pharmaceutical, devices and animal health companies with their product development, expansion or diversification to establish relationships in foreign territories.

- Access to Capital via hedge funds, private investors and partnerships aiming speed to market. This includes finding local country partners or investors, licensing and expanding their developing products.

- Support strategic decisions on funding Development and Operations from early stages through regulatory submission/approval and product launch, defining strategic/operational approaches, importing/exporting and developing effective strategies that facilitate access to specialized medicines globally.

- Our process connects tools, methods, systems, mindsets and behaviors towards better results.

OPERATIONS EXCELLENCE

-Even well managed companies use only a small piece of its creative and productive potential. We partner with the leadership team, supporting them step out of their day to day pressure to be able to see the bigger picture, identify opportunities and improve their management skills.

-Integrated production value stream connecting departments and support functions

-Customer set the pace of Manufacturing and Supply Chain

-Virtual plant through our unique SIMULA PHARMA system allow you to simulate any desired change and immediately visualize all performance and financial impacts to your company, at the Unit cost level (see www.PGIfarma.com.br partner).

-Everyone engaged in improving performance (kaizens) as part of day to day job.

-Leaders are teachers, focused on developing people as problem solvers

-Be prepared to the future, know Industry 4.0 and other tools.

expertise
Biosimilars

Biosimilars / Vaccines

Dynami Pharma and its main partners, among them, DFA Consulting Services, MedicaRx Inc., SPD Consult, Alpha Partners Brazil, Eurolife Investments Inc., Farmacore Biotech, PGI Pharma, with its founders have been on the cutting edge of the global biosimilars market. Our insights have been formed via interactions with regulatory agencies, governments, investors, market innovators and experience running and building biosimilar companies.
We were part of the Operation Warp Speed in the USA, 
a program designed to find an effective vaccine for COVID-19, support manufaturers to produce and creating an effective distribution as soon as possible.
Strong Partnerships

We partner with Farmacore Biotech (www.farmacore.com.br), DFA Consulting LLC   (www.DFAconsultingservices.com), MedicaRx (www.medikaRxinc.com), PGI Pharma (www.PGIfarma.com)  who developed the SIMULA PHARMA system already being used for many companies in the USA, Brazil, Argentina, Colombia, Mexico, a very unique tool that allows simulations on any and all changes in processes, equipment, labor, return of investments, performance etc. visualizing immediately all financial impacts in your company, up to the Unit Cost per product.    

Our insights have been formed through decades of running networks of plants and organizations and via interactions with regulatory agencies, governments, investors and market innovators.

Contact Us

Thanks! Message sent.

Contact
bottom of page